"Adverse events" is a terribly clinical sounding description of such tragic outcomes. Perhaps more people should read the personal account of Jenny, a University of California, Berkeley professor's daughter who lost her life after getting the shot. (See Jenny's blog http://jenjensfamily.blogspot.com/).

Few parents would want their child to be among the 39 deaths to girls who had just taken the Gardasil shot. Nor would most parents want their child to take the risk of hospitalization, disability, or a life-threatening illness. Yet, heretofore, accurate information has not been forthcoming, including the fact that many additional reported cases of "adverse effects" had too few details. Thus, those cases were excluded from the study.

Even with the new information, numerous questions remain about the safety as well as the efficacy of the drug. Further, there are questions about the marketing of the drug. In fact, cervical cancer is relatively uncommon in the United States. The American Cancer Society reports under 4,000 deaths per year compared to the 250,000 deaths in other areas of the world, primarily in poor countries.

Plus, there are questions about Merck's grants to professional medical associations who promoted the vaccine's use without fully explaining the risks involved with taking the drug. Some doctors ask if the big push to sell Gardasil is Merck's method of making up the lost sales after their popular anti-pain medication, Vioxx, was banned. These facts raise questions about the appropriateness of recommending such a high-risk drug for widespread use among American children and teenagers.

In the wake of all the side effects, Merck has added warnings to the label on the drug. The warnings on all the labels state that some children receiving Gardasil have subsequent problems, such as autoimmune diseases, musculoskeletal disorders, paralysis, and seizures. Further, some doctors worry that not enough young girls were included in the clinical trials of the drug; they believe that there is really no way to know how pre-teen and teenage girls will react to such a high-powered vaccine. Merck acknowledges that the drug is effective for only five years, so giving the drug to 11 to 12 year olds hardly seems warranted.

Critics are especially concerned about the risk-benefit ratio of taking the HPV vaccine. Gardasil is very costly and most physicians recommend that women continue to get Pap smears, even if they have taken Gardasil. The known benefit of the regular Pap smear screening in preventing most cases of cervical cancer makes the benefit of the HPV risk uncertain. In fact, Those mothers around that picnic table and the thousands of other parents concerned about the well-being of their daughters need to have all the facts and know the risks involved before subjecting their little girls to this new vaccine. States need to have these facts before discussing the possibility of mandating the vaccines for all pre-teen and teenage girls.

August 28, 2009


For related links, read this publication online at:
http://www.cwfa.org/articles/17595/BLI/dotcommentary/index.htm

Dr. Janice Shaw Crouse is a Senior Fellow of Concerned Women for America's Beverly LaHaye Institute. She writes about contemporary issues that affect women, family, religion and culture in her regular column "Dot.Commentary."